[Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents]
- PMID: 580020
[Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents]
Similar articles
-
[Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone].Arzneimittelforschung. 1978;28(2):337-41. Arzneimittelforschung. 1978. PMID: 346022 Clinical Trial. German. No abstract available.
-
[Aspects of azapropazone and basic therapy of pheumatism considering drug interactions (author's transl)].Arzneimittelforschung. 1977;27(11):2170-4. Arzneimittelforschung. 1977. PMID: 580024 German. No abstract available.
-
[Plasma azapropazone level during combination therapy of rheumatoid diseases].Verh Dtsch Ges Inn Med. 1978;(84):1502-5. Verh Dtsch Ges Inn Med. 1978. PMID: 311119 German. No abstract available.
-
Immunosuppressive therapy in severe rheumatoid arthritis.Mod Treat. 1971 Nov;8(4):778-86. Mod Treat. 1971. PMID: 4946106 Review. No abstract available.
-
Immunosuppressive drugs in rheumatoid arthritis.Mod Trends Rheumatol. 1971;2:174-98. Mod Trends Rheumatol. 1971. PMID: 4344785 Review. No abstract available.
Cited by
-
Disposition of azapropazone in chronic renal and hepatic failure.Eur J Clin Pharmacol. 1981;20(2):147-55. doi: 10.1007/BF00607152. Eur J Clin Pharmacol. 1981. PMID: 7262176 No abstract available.